Latest News - Skin Cancer

Tuesday, January 15, 2019

Study: States with Fewer Melanoma Diagnoses Have Higher Death Rates

States with fewer melanoma diagnoses actually have higher death rates, report researchers at University of Utah Health. The researchers conducted a state-by-state analysis to understand the geograp…

Read the full story

Thursday, January 03, 2019

Bristol-Myers Squibb to Acquire Celgene

Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …

Read the full story

Tuesday, December 18, 2018

New Study Seeks to Improve Skin Cancer Prevention in Young Adults Via a New Website

Researchers out of Rutgers Cancer Institute of New Jersey and colleagues from across the country are conducting a study to evaluate the reach and effectiveness of an online program targeted at skin ca…

Read the full story

Friday, December 07, 2018

Naked Eye, Smart Phone Apps May Miss Melanomas

The naked eye alone is not enough to accurately diagnosis skin cancer and smart phone apps may also miss melanomas, according to a new review published in The Cochrane Library as part of a Special Col…

Read the full story

Thursday, December 06, 2018

Low 3% Keloid Recurrence Found in Multicenter Case Series of Patients Treated with SRT

Sensus Healthcare, Inc., a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), sh…

Read the full story

Thursday, November 29, 2018

Cosmetic Surgery Forum Kicks Off in Las Vegas

With new and returning faculty, controversial and timely topics, and an all new venue, Cosmetic Surgery Forum (CSF) kicks off its 10th year at the chic Cosmopolitan Hotel. The meeting features 50 sess…

Read the full story

Wednesday, November 21, 2018

Nanoparticulate-based Sunscreens May Not Be So Dangerous After All

Zinc oxide nanoparticles used in sunscreen neither penetrate the skin nor cause cellular toxicity after repeated applications, according to a study out of University of Queensland (UQ) and University …

Read the full story

Tuesday, November 20, 2018

LEO, PellePharm Form Collaboration Focused on Innovation

A new strategic development and commercialization collaboration between LEO Pharma and PellePharm is intended to address unmet medical needs across various skin diseases with no approved treatments, t…

Read the full story

Tuesday, November 13, 2018

Study Highlights Unique Characteristics of Melanoma Patients Who Use Tanning Beds

Younger individuals and females are more likely to use tanning beds, and as a result they tend to develop melanoma earlier, according to new research published in the December issue of the Journal of …

Read the full story

Thursday, November 01, 2018

AAD Releases New Melanoma Guidelines

As National Healthy Skin Month begins, the American Academy of Dermatology’s (AAD) new melanoma guidelines shed light on risk of melanoma prognosis during pregnancy, the role of formal gene…

Read the full story

Monday, October 29, 2018

Skin Cancer Foundation: Champions for Change Gala Raises $600,000

The Skin Cancer Foundation’s 22nd annual Gala raised $600,000 to support the organization’s educational campaigns, community programs, and research initiatives. More than 400 guests attend…

Read the full story

Monday, October 29, 2018

Researchers Identify Genes Involved in Skin Cancer

Researchers at the Health Sciences department of the Universitat Jaume I (UJI) of Castellón, Spain, have identified the genes responsible for sun sensitivity and skin cancer vulnerability. The …

Read the full story

Thursday, October 25, 2018

Pennsylvania Passes SUNucate, Allowing Sunscreen Use and Protective Clothing at School

Pennsylvania became the 17th state to allow children to possess and apply sunscreen at school. Governor Tom Wolf approved HB 1228, a piece of legislation based on American Society for Dermatologic …

Read the full story

Monday, October 22, 2018

Opdivo Plus Yervoy Demonstrates Durable Four-Year Survival Benefits in Advanced Melanoma

Four-year data from the Phase 3 CheckMate-067 clinical trial -- the longest follow-up to date -- continue to demonstrate durable, long-term survival benefits with the first-line combination of Op…

Read the full story

Friday, September 28, 2018

FDA Approves Regeneron's Libtayo, First Treatment for Metastatic or Locally Advanced SCC

Libtayo (cemiplimab-rwlc) injection (Regeneron Pharmaceuticals, Inc.)  is now FDA-approved for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma…

Read the full story
Load More